Sunshine Biopharma Inc. (SBFM) income statement
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$0.24+0.02 (+9.02%)
Close on Oct 19, 2026Market cap $9.11MP/E –Yield –
Sunshine Biopharma Inc. financial ratios
See a number that looks wrong?